Stocks360

Rydex Biotechnology Inv (RYOIX)

Stock analysis · NASDAQ · Financial Services · Asset Management

Share: Facebook X WhatsApp SMS
$98.81

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$104.26M
PE (TTM)
N/A
EPS (TTM)
N/A
Dividend Yield
N/A
Beta
0.68
Day Range
$97.79 – $98.81
52-wk Range
$72.00 – $98.81
Avg Volume
N/A
Volume
0.00

Rydex Biotechnology Inv (RYOIX) is a publicly traded company in the Financial Services sector. Latest price: $98.81. Market cap $104.26M. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $79.07 2026-10-29 · $98.81 (+24.97%)

Proprietary Signals

Signal snapshot temporarily unavailable.

About Rydex Biotechnology Inv

Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Peers

Recent News

  • No recent news available.

Related

Browse more tickers: sitemap